RocketTickers

Amgen Announces Positive Top-Line Results From Otezla® (apremila

Long
NASDAQ:AMGN   Amgen Inc.
AMGN: Amgen
2020-05-06 09:00:00
Amgen Announces Positive Top-Line Results From Otezla® (apremilast) Phase 3 ADVANCE Study In Mild-To-Moderate Plaque Psoriasis
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.